文献速递角膜与眼表疾病

FGF10通过上调SLC7A11保护干眼诱导的角膜上皮氧化应激与内质网应激

FGF10 Protects the Corneal Epithelium From Dry Eye-Induced Oxidative and ER Stress Via Upregulation of SLC7A11.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

该研究在小鼠干眼模型和HCE-2细胞中探讨FGF10对角膜上皮的保护作用及机制。FGF10局部滴眼可改善角膜上皮完整性、降低ROS和内质网应激、减少凋亡,并上调SLC7A11;沉默SLC7A11可阻断FGF10的保护作用,而过表达SLC7A11可重现该保护效应。

要点

  • 小鼠干眼模型中,局部FGF10(5、25、125 μg/mL)滴眼七天改善角膜上皮完整性并降低氧化应激和内质网应激。
  • FGF10上调HCE-2细胞和干眼角膜中SLC7A11蛋白水平。
  • 沉默SLC7A11可阻断FGF10在体外降低ROS、内质网应激和凋亡的作用。

核心结论

  • FGF10保护小鼠角膜上皮和HCE-2细胞免受氧化应激、内质网应激和凋亡,部分通过上调SLC7A11实现。
  • FGF10-SLC7A11通路是干眼有前景的治疗靶点。

研究设计与样本

  • 研究使用东莨菪碱注射和低湿度气流诱导的小鼠干眼模型,评估FGF10局部滴眼七天的治疗效果。
  • 体外使用高渗应激的HCE-2细胞,以100 ng/mL FGF10处理并进行RNA测序。
  • 通过siRNA介导的SLC7A11沉默(HCE-2细胞)和AAV介导的SLC7A11过表达(小鼠模型)验证SLC7A11的功能重要性。

主要发现

  • FGF10处理显著改善干眼小鼠角膜上皮完整性,降低荧光素染色、ROS水平和内质网应激标志物,同时增加Bcl-2并降低BAX。
  • RNA测序显示FGF10激活抗氧化信号通路并上调SLC7A11表达。
  • FGF10增加HCE-2细胞和干眼角膜中SLC7A11蛋白水平。
  • 体外沉默SLC7A11阻止FGF10诱导的ROS、内质网应激和凋亡降低。
  • AAV介导的SLC7A11过表达在干眼小鼠中重现了FGF10处理的保护效应。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the protective effect of fibroblast growth factor 10 (FGF10) on the corneal epithelium in dry eye disease (DED) and reveal the underlying mechanism. METHODS: DED mouse model was induced via scopolamine injections and low-humidity airflow to evaluate the therapeutic effects of FGF10. Mice received topical FGF10 (5, 25, or 125 µg/mL) or vehicle for seven days. Corneal fluorescein staining, oxidative stress (ROS levels), endoplasmic reticulum (ER) stress, and apoptosis were evaluated. To investigate protective mechanisms on corneal epithelium cells, hyperosmolar-stressed HCE-2 cells were treated with 100 ng/mL FGF10, and RNA sequencing was performed. Transcriptomic analysis identified SLC7A11, a key regulator of cellular antioxidant defense, as significantly upregulated by FGF10. SLC7A11's functional importance was validated through siRNA-mediated silencing in HCE-2 cells and AAV-mediated overexpression in mouse model. RESULTS: FGF10 treatment significantly improved corneal epithelial integrity in dry eye mice, reducing fluorescein staining, ROS level, and ER stress markers, while increasing Bcl-2 and decreasing BAX. RNA sequencing revealed that FGF10 stimulated antioxidant signaling pathways and upregulated SLC7A11 expression. FGF10 also increased SLC7A11 protein levels in HCE-2 cells and dry eye corneas. Silencing of SLC7A11 in vitro prevented FGF10-induced reductions in ROS, ER stress, and apoptosis. Furthermore, AAV-mediated overexpression of SLC7A11 in dry eye mice recapitulated the protective effects observed with FGF10 treatment. CONCLUSIONS: FGF10 protects mouse corneal epithelium and HCE-2 cells from oxidative stress, ER stress, and apoptosis, partially through SLC7A11 upregulation. The FGF10-SLC7A11 pathway represents a promising therapeutic target in dry eye.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zha Z, Li J, Xie S, et al. FGF10 Protects the Corneal Epithelium From Dry Eye-Induced Oxidative and ER Stress Via Upregulation of SLC7A11. Invest Ophthalmol Vis Sci. 2025. PMID: 40552917. doi:10.1167/iovs.66.6.72

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。